JP2010501594A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010501594A5 JP2010501594A5 JP2009525853A JP2009525853A JP2010501594A5 JP 2010501594 A5 JP2010501594 A5 JP 2010501594A5 JP 2009525853 A JP2009525853 A JP 2009525853A JP 2009525853 A JP2009525853 A JP 2009525853A JP 2010501594 A5 JP2010501594 A5 JP 2010501594A5
- Authority
- JP
- Japan
- Prior art keywords
- variable region
- glycoprotein
- hcv
- modified
- linker sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2006904635 | 2006-08-25 | ||
| AU2006904635A AU2006904635A0 (en) | 2006-08-25 | Recombinant E2 Envelope Glycoprotein for Improved Treatment of HCV virus | |
| AU2006906090 | 2006-11-01 | ||
| AU2006906090A AU2006906090A0 (en) | 2006-11-01 | Recombinant HCV E2 Glycoprotein for use in HCV Vaccine Treatment | |
| AU2006906282 | 2006-11-10 | ||
| AU2006906282A AU2006906282A0 (en) | 2006-11-10 | Recombinant HCV E2 Glycoprotein for use in HCV Vaccine Treatment | |
| PCT/AU2007/001221 WO2008022401A1 (en) | 2006-08-25 | 2007-08-24 | Recombinant hcv e2 glycoprotein |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014185095A Division JP5999524B2 (ja) | 2006-08-25 | 2014-09-11 | 組換えｈｃｖｅ２糖タンパク質 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2010501594A JP2010501594A (ja) | 2010-01-21 |
| JP2010501594A6 JP2010501594A6 (ja) | 2010-04-15 |
| JP2010501594A5 true JP2010501594A5 (cg-RX-API-DMAC7.html) | 2010-10-07 |
| JP5674310B2 JP5674310B2 (ja) | 2015-02-25 |
Family
ID=39106399
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009525853A Expired - Fee Related JP5674310B2 (ja) | 2006-08-25 | 2007-08-24 | 組換えｈｃｖ ｅ２糖タンパク質 |
| JP2014185095A Expired - Fee Related JP5999524B2 (ja) | 2006-08-25 | 2014-09-11 | 組換えｈｃｖｅ２糖タンパク質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014185095A Expired - Fee Related JP5999524B2 (ja) | 2006-08-25 | 2014-09-11 | 組換えｈｃｖｅ２糖タンパク質 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US8535686B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2061805B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5674310B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101500017B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101563362B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007288129B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2661814A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008022401A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5674310B2 (ja) * | 2006-08-25 | 2015-02-25 | ザ・マクファーレーン・バーネット・インスティテュート・フォー・メディカル・リサーチ・アンド・パブリック・ヘルス・リミテッド | 組換えｈｃｖ ｅ２糖タンパク質 |
| US9758794B2 (en) | 2008-04-22 | 2017-09-12 | Rutgers, The State University Of New Jersey | HCV E2 construct compositions and methods |
| WO2009131681A2 (en) * | 2008-04-22 | 2009-10-29 | Rutgers, The State University | Hcv e2 construct compositions and methods |
| JP2011521985A (ja) * | 2008-06-03 | 2011-07-28 | オカイロス アーゲー | Ｈｃｖ感染の予防および治療のためのワクチン |
| CA2658714A1 (en) | 2009-03-17 | 2010-09-17 | Thomas Krey | Hcv-derived polypeptides and uses thereof |
| CN102199613A (zh) | 2010-03-25 | 2011-09-28 | 国立大学法人东京大学 | 感染性丙型肝炎病毒高生产hcv突变体及其应用 |
| CN103354748B (zh) | 2010-08-04 | 2016-09-28 | 麦克法兰博尼特医学健康研究公司 | 修饰的丙型肝炎病毒蛋白 |
| CA2856565A1 (en) * | 2010-11-26 | 2012-05-31 | The Macfarlane Burnet Institute For Medical Research And Public Health Ltd. | Multimeric hepatitis virus (hcv) envelope 2 (e2) glycoprotein |
| US20130084301A1 (en) * | 2011-08-30 | 2013-04-04 | Steven Foung | Cluster of Neutralizing Antibodies to Hepatitis C Virus |
| CN103102394B (zh) * | 2013-02-27 | 2014-06-25 | 北京大学人民医院 | 丙型肝炎病毒b细胞表位肽puhi49及其应用 |
| EP3519424A4 (en) * | 2016-09-29 | 2020-06-03 | Macfarlane Burnet Institute for Medical Research and Public Health Limited | ASSEMBLED GLYCOPROTEINS |
| CA3148840A1 (en) * | 2019-07-26 | 2021-02-04 | The Scripps Research Institute | Engineered hcv e2 immunogens and related vaccine compositions |
| CN115843270A (zh) * | 2020-05-11 | 2023-03-24 | 麦克法兰布奈特医疗研究与公共健康研究所有限公司 | 包括缺失可变结构域的e2多肽的丙型肝炎核酸疫苗 |
| CN112730851B (zh) * | 2021-03-31 | 2021-06-22 | 南京立顶医疗科技有限公司 | 一种高灵敏SARS-CoV-2中和抗体的检测方法、检测试剂盒 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1076092A3 (en) | 1994-10-21 | 2001-03-28 | Innogenetics N.V. | Sequences of hepatitis C virus type10 and their use as prophylactic, therapeutic and diagnostic agents |
| EP1127170A4 (en) * | 1998-11-05 | 2005-04-27 | Univ Leland Stanford Junior | HUMAN MONOCLONAL ANTIBODIES OF THE HEPATITIS C VIRUS (HCV) PAN |
| WO2001021807A1 (en) | 1999-09-23 | 2001-03-29 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health Services | Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof |
| WO2002022155A1 (en) | 2000-09-13 | 2002-03-21 | Hawaii Biotechnology Group, Inc. | Immunogenic composition of hepatitis c and methods of use thereof |
| AR035868A1 (es) * | 2001-04-24 | 2004-07-21 | Innogenetics Nv | Un acido nucleico recombinante que codifica una proteina de un peptido lider de lisozima de ave o equivalente funcional, un vector que lo comprende, una celula huesped, un metodo para producir una proteina de envoltura del hcv o una parte de la misma. |
| IL145440A0 (en) | 2001-09-13 | 2002-06-30 | Xtl Biopharmaceuticals Ltd | Synthetic hcv envelope proteins and their use for vaccination |
| EP1716250B1 (en) * | 2004-01-07 | 2015-08-05 | Third Wave Technologies, Inc. | Determination of hepatitis c virus genotype |
| JP5674310B2 (ja) * | 2006-08-25 | 2015-02-25 | ザ・マクファーレーン・バーネット・インスティテュート・フォー・メディカル・リサーチ・アンド・パブリック・ヘルス・リミテッド | 組換えｈｃｖ ｅ２糖タンパク質 |
-
2007
- 2007-08-24 JP JP2009525853A patent/JP5674310B2/ja not_active Expired - Fee Related
- 2007-08-24 EP EP07784854.7A patent/EP2061805B1/en active Active
- 2007-08-24 CN CN200780036968.8A patent/CN101563362B/zh active Active
- 2007-08-24 US US12/438,657 patent/US8535686B2/en not_active Expired - Fee Related
- 2007-08-24 CA CA002661814A patent/CA2661814A1/en not_active Abandoned
- 2007-08-24 KR KR1020097005994A patent/KR101500017B1/ko not_active Expired - Fee Related
- 2007-08-24 WO PCT/AU2007/001221 patent/WO2008022401A1/en not_active Ceased
- 2007-08-24 AU AU2007288129A patent/AU2007288129B2/en active Active
-
2013
- 2013-08-14 US US13/967,059 patent/US9598467B2/en not_active Expired - Fee Related
-
2014
- 2014-09-11 JP JP2014185095A patent/JP5999524B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010501594A5 (cg-RX-API-DMAC7.html) | ||
| US6951646B1 (en) | Anti hepatitis C virus antibody and uses thereof | |
| Goh et al. | Neutralizing monoclonal antibodies to the E2 protein of chikungunya virus protects against disease in a mouse model | |
| Keck et al. | Affinity maturation of a broadly neutralizing human monoclonal antibody that prevents acute hepatitis C virus infection in mice | |
| ES2926511T3 (es) | Anticuerpos anti-CLEVER-1 humanizados y utilización de los mismos | |
| JP2012504602A5 (cg-RX-API-DMAC7.html) | ||
| EA201170353A1 (ru) | Антитела против гепатита с и их применение | |
| JP2012531219A5 (cg-RX-API-DMAC7.html) | ||
| JP2018512124A5 (cg-RX-API-DMAC7.html) | ||
| JP2005528914A5 (cg-RX-API-DMAC7.html) | ||
| Arribillaga et al. | Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus | |
| Zhou et al. | Monoclonal antibodies to the hypervariable region 1 of hepatitis C virus capture virus and inhibit virus adsorption to susceptible cells in vitro | |
| JP2018537117A5 (cg-RX-API-DMAC7.html) | ||
| JP2006504645A5 (cg-RX-API-DMAC7.html) | ||
| JP5897024B2 (ja) | 組成物および方法 | |
| JP2008532559A5 (cg-RX-API-DMAC7.html) | ||
| JP2006523185A5 (cg-RX-API-DMAC7.html) | ||
| US20080248042A1 (en) | Monoclonal antibody cross-reactive against infective agent causing a B-cell expansion and IgG-Fc | |
| CN105254756B (zh) | 一种针对丙型肝炎病毒包膜蛋白e2的单克隆抗体及应用 | |
| El-Awady et al. | Conserved peptides within the E2 region of Hepatitis C virus induce humoral and cellular responses in goats | |
| TWI432211B (zh) | 與登革病毒相關之胜肽及抗體以及其用途 | |
| EP2705369B1 (fr) | Procédé pour la détection d'une infection par le virus de la dengue | |
| Takao et al. | Antibody reactive to a hepatitis C virus (HCV)‐derived peptide capable of inducing HLA‐A2 restricted cytotoxic T lymphocytes is detectable in a majority of HCV‐infected individuals without HLA‐A2 restriction | |
| CN107286237B (zh) | 一种抗丙型肝炎病毒抗体的获取以及应用 | |
| CN113876939A (zh) | 登革次单位疫苗组成物 |